Searched for
GSK BUYBACK
Stocks in the news: TechM, PNB, DHFL, Coal India, Jubilant Foodworks, Zee and Dish TVHere are a few stocks which may buzz the most on Tuesday.05 Feb, 2019, 08.02 AM IST- Unilever used HUL buyback gains to secure GSK health dealUnilever bought back HUL shares at Rs 600 apiece 5 years ago which has appreciated to Rs 1,700 now. Unilever diluted 5.3% HUL stake in GSK ...11 Dec, 2018, 07.41 AM IST
- Post GSK deal, analysts raise HUL target price by up to 17%Credit Suisse has raised FY21 earnings estimates by 6.5 per cent, lifting its target price to Rs 1,900 from Rs 1,770.05 Dec, 2018, 08.21 AM IST
- Novartis slumps after Q4 numbers, buyback announcementCompany said its standalone total income from operations stood at Rs 167.27 cr for Q4, compared with Rs 207.64 cr in the corresponding peri...27 May, 2016, 03.42 PM IST
- 10 stocks that outperformed the market in 2015These ten stocks have outperformed the broader market and have stood firm on each of the 10 days in 2015 when the market fell sharply.25 Sep, 2015, 10.14 AM IST
- GSK India to benefit from global business swap deal with NovartisGlaxo will get Novartis’ vaccine portfolio, including anti-rabies products such as Rabipur, while transferring its smaller oncology busines...26 May, 2014, 04.00 AM IST
- GSK Pharma open offer begins today; stock hits 52-week highGSK Pharma continued to attract investor attention after its UK-based parent company GlaxoSmithKline’s voluntary open offer started today.18 Feb, 2014, 10.38 AM IST
- $1 billion bet: GSK Pharma a short-term sell, long-term buy, say expertsThe stock is at rich valuations despite low sales and profit growth. The open offer by its parent firm is attractively priced, say experts.16 Dec, 2013, 04.28 PM IST
- GSK Pharma rallies 20% as parent initiates open offerThe parent of GlaxoSmithKline Pharmaceuticals Ltd plans to increase its stake from 50.7 per cent to up to 75 per cent at an offer price of ...16 Dec, 2013, 09.47 AM IST
- Should you focus on MNC stocks?Despite the open offer by HUL and the expectation of other MNCs following suit, investors should be cautious and not buy into the hype.13 May, 2013, 10.02 AM IST
- GlaxoSmithKline Plc's open offer for GSKCH to start on January 17The UK-based GlaxoSmithKline Plc's open offer to acquire 31.8 per cent stake in its Indian subsidiary GlaxoSmithKline Consumer Healthcare w...04 Dec, 2012, 09.32 PM IST
- GSK Consumer’s buyback attractive for shareholders: CitiGlaxoSmithKline’s open offer to buyback shares of subsidiary GSK Consumer Healthcare is attractive for the shareholders, says Citi report.28 Nov, 2012, 05.00 PM IST
- GlaxoSmithKline Consumer Healthcare lines up 5,222 crore share buyback offerThe UK-based company plans to raise stake in Indian unit by 31.8 per cent through an open offer at a 28 per cent premium.27 Nov, 2012, 06.11 AM IST
- UK-based healthcare major GlaxoSmithKline to invest Rs 5,220 cr in India subsidiaryGlaxoSmithKline today announced plans to infuse about Rs 5,220 crore in its Indian subsidiary GSKCH by increasing stake to 75% from 43.2% a...26 Nov, 2012, 06.54 PM IST
- GSK to raise stake in GlaxoSmithKline Consumer Healthcare via open offerGlaxoSmithKline plans to raise its stake in its Indian consumer products arm to 75 per cent from 43.16 per cent through an open offer.26 Nov, 2012, 11.38 AM IST
- Strides Acrolab: Drug licence, supply gains turn it onTHE Bangalore-based pharma major, Strides Arcolab, saw its stock price rising by 8% on Wednesday on the back of news of the company collabo...08 Jan, 2010, 10.08 AM IST
- ‘Productivity of global pharma R&D pipelines has fallen’The Indian arms of most global pharma giants have so far remained under-sized, rather off their parent’s radar for sometime now. But are th...05 Feb, 2009, 12.53 AM IST
Load More
